Top Markets
Coin of the day
Health-Chem Corporation Health-Chem Corporation

Health-Chem Corporation

HCLC
Classificação em ações #40843
Health-Chem Corporation, operating through its subsidiary, Transderm... Health-Chem Corporation, operating through its subsidiary, Transderm Laboratories Corporation, specializes in the research, development, manufacturing, and commercialization of transdermal drug delivery systems throughout the United States. Among its key products are transdermal nitroglycerin patches, formulated to provide relief for vascular and cardiovascular symptoms linked to angina pectoris (commonly known as chest pain) via skin absorption. The company additionally offers contract research and development services to third-party clients. Health-Chem Corporation employs a multifaceted sales strategy, directly engaging with wholesalers, distributors, prominent retail pharmacy chains, mail-order pharmacies, and group purchasing organizations. Its products also reach the market indirectly through independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management firms. Founded in 1970, the company's headquarters are situated in Emigsville, Pennsylvania.
Preço da ação
$0.0001
Última sincronização: 2025-01-02
Valor de mercado
$73.99K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Health-Chem Corporation (HCLC)

Categoria

Receita da Health-Chem Corporation (HCLC)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Health-Chem Corporation, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Health-Chem Corporation de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$46.34B -
US
$25.11B -
US
- -
CN
$2.71B -
US
$4.55B -
US